MedTrace Logo

Optical Coherence Tomography in Multiple Sclerosis Patients

NCT01774123 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2014-06-03

No results posted yet for this study

Summary

To evaluate the ability of different spectral domain optical coherence tomography (OCT) devices, as well as different acquisition and analysis packages, to detect disease progression in patients with multiple sclerosis with and without a history of optic neuritis

Conditions

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Peter K. Kaiser, MD · Cleveland Clinic Cole Eye Institute

  • Robert Bermel, MD · Cleveland Clinic Mellen Center

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01774123 on ClinicalTrials.gov